Navigation Links
NSBRI Industry Forum Launches SMARTCAP-Accel, a Grant Funding Opportunity to Catalyze Development of Products for Spaceflight
Date:6/11/2013

HOUSTON, June 11, 2013 /PRNewswire-USNewswire/ -- The NSBRI Industry Forum today announced a new funding opportunity for small U.S. companies with biomedical products that hold promise for use in space.

(Logo: http://photos.prnewswire.com/prnh/20130611/DC29942LOGO)

The NSBRI Industry Forum has initiated a new grant funding program for small, U.S.-based companies who are in, or have graduated from, business accelerators.  NSBRI is partnering with prominent business accelerators in the biotechnology, health and health-IT sectors to identify the best and brightest candidates for the program, which seeks innovative solutions to the health care challenges inherent to spaceflight. Companies, in partnership with sponsoring accelerators, can submit applications for the SMARTCAP-Accel program from June 11, 2013 through July 22, 2013, online at www.smartcap.org.

Launched today at a joint media event with the Office of Economic Growth and Innovation of the City of Louisville, Kentucky, and its new accelerator XLerateHealth, the SMARTCAP-Accel program marks an expansion of NSBRI's already highly successful SMARTCAP program. Like the original program, SMARTCAP-Accel will offer small U.S. companies the opportunity to receive non-dilutive project funding and collaboration opportunities with NSBRI and its research partners.

Project budgets ranging from $10,000 to $200,000 will be considered, but to maximize program funds all SMARTCAP-Accel grants must be matched with new investments from another funding source.

Dr. Dorit Donoviel, NSBRI's Industry Forum Lead, believes that this program, a partnership between government, academia and industry, will advance products in a more cost-efficient and timely manner. "Administering healthcare in space requires innovative medical solutions that may stall in the laboratory due to insufficient funding and a clear path to overcome regulatory hurdles," Donoviel explains. "The resources required to move a novel technology from 'bench to bedside' for space and Earth are significant and require expertise in science, medicine, engineering, and business," she added. "For all these reasons, it is critical that government, universities, and the private sector partner to develop promising technologies that meet a medical need for spaceflight and for Earth and that's what we are doing with SMARTCAP-Accel."

According to Dr. Ted Smith, Chief of Economic Growth and Innovation for the City of Louisville and a member of the NSBRI Industry Forum Steering Council, the program helps open up new thinking in a way that will benefit tax-payers. "The SMARTCAP program harnesses the creative energy in innovators and entrepreneurs out there that would never respond to a life sciences procurement opportunity," remarked Smith. "Essentially, the SMARTCAP and SMARTCAP-Accel programs are crowd-sourced problem solving, and that is probably the most tax-efficient thing we can do to generate effective, innovative solutions." He added, "Accelerators have become a major pathway for entrepreneurs to obtain capital and mentorship. These accelerators see hundreds of applications each cycle, and vet the opportunities - and NSBRI benefits from that pipeline of entrepreneurial refinement."

Successful SMARTCAP-Accel applications will be aimed at developing products that can better safeguard the health of humans working in space, as well as fulfill unmet medical needs on Earth.

The constraints on health care in space are similar to those experienced in remote or under-resourced regions on Earth. Technology solutions must be largely non-invasive, user-friendly for non-expert operators, compact, lightweight, and consume minimal power, water or other resources.  IT solutions must stand alone and not require internet connectivity.

"For these reasons, we have seen time and time again that products developed for space possess unique features that lead to commercial advantages on Earth," Dr. Donoviel explained.

The human health risks or medical care challenges related to space travel are wide ranging.  They include:

  • Exposure to ionizing radiation;
  • Muscle and bone loss, due to microgravity;
  • Intracranial hypertension and related visual impairment;
  • Renal stone formation;
  • Sleep loss and circadian disruption;
  • Psychiatric/behavioral issues associated with isolation and confinement;
  • Routine health surveillance;
  • Emergency/critical care; and
  • Clinical decision support for autonomous care

For a more complete list of risks associated with human space flight see www.nsbri.org and http://humanresearchroadmap.nasa.gov/

Eligibility

Accelerators: U.S. based accelerators that have directly funded companies within the past 12 months may nominate up to two applicants that have already been selected for support by the accelerator.

Nominees:  Nominated companies must either be currently receiving support from the accelerator or must have successfully exited the accelerator.  To be considered, companies must be based in the U.S., have 500 or fewer employees, and be one of up to two companies sponsored by a qualifying accelerator.

Projects: A proposed project should meet at least one key milestone along the path to product commercialization.  Examples of desirable projects include:

  • Proof of concept studies;
  • Refinement of prototypes;
  • Re-formulation;
  • Safety;
  • Regulatory; and
  • Usability testing

NSBRI will work with successful candidates to develop a work plan that is aligned with both the terrestrial and space applications of the product.

About NSBRI
The National Space Biomedical Research Institute, NSBRI, is a 501(c)3 organization funded by NASA. Its mission is to lead a national program to mitigate the health risks related to long-duration spaceflight and to apply the discoveries to improve life on Earth. Annually, the Institute's science, technology and education projects take place at approximately 60 institutions and companies across the United States.

About NSBRI Industry Forum
The NSBRI Industry Forum was established to accelerate the development and commercialization of products to enhance health in space and on Earth.  

About the Office of Economic Growth and Innovation of the City of Louisville, Kentucky
The Office of Economic Growth and Innovation fosters a robust business climate, by promoting job creation, helping business navigate potential financing, meeting workforce needs, creating amenities within our region, and balancing growth by enhancing the environment, in order to improve the quality of life in Louisville Metro.


'/>"/>
SOURCE National Space Biomedical Research Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. NSBRI Funds Cerebrotech to Accelerate Development of Brain Monitoring Device
2. NSBRI Renews Space Life Sciences Graduate Programs at MIT, Texas A&M
3. Metabolix Executives to Present at Leading Industry Conferences
4. Global Catalysts Industry 2013-2018: Trend, Profit, and Forecast Analysis - Benchmark the Worlds Top 5 Drug Companies
5. Heptares to Present at Upcoming Biotech Industry Conferences
6. Adult Acne Treatment Explains a New Upcoming Study that may Change the Acne Treatment Industry
7. Leveraging an Academic-Industry Partnership for Commercial Success, New Life Science Webinar Hosted By Xtalks
8. United Airlines and AltAir Fuels to Bring Commercial-Scale, Cost-Competitive Biofuels to Aviation Industry
9. Lucintel Estimates Global Agro-Food Products Industry to Reach $1,148.3 Billion By 2018
10. Lucintel Report Outlines $821.8 Billion Market for Global Basic Petrochemicals Industry by 2018
11. Lucintel Analyzes EMC in Global Semiconductor Packaging Industry: Market Expected to Reach $1,702 Million in 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... ... separable adhesive layers, as issued by the U.S. Patent & Trademark Office (USPTO). ... to combining electronics and health monitoring. This invention will be critical to the ...
(Date:3/29/2017)...  Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions ... results for the fourth quarter and full year ... a pivotal year for us with our first ... agreements, major reimbursement progress with Medicare, positive medical ... addition we cleared our 2 nd generation ...
(Date:3/29/2017)... year,s petition to the White House signed by 120,000 ... generate awareness on the importance of new organic medicines and nutritional ... place. ... this month Health Advance (OTC PINK: HADV ), ... announced its endeavors on this generally recognized as safe ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... announce that Nerium International Mexico has been approved as an active member of ... achieve satisfaction and protection among distributers and consumers in relationship marketing. This professional ...
Breaking Biology Technology:
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ... Iris-Scan, wird seine erstklassige biometrische Lösung zur ... 835 mit X16 LTE auf dem Mobile ... März) am Qualcomm-Stand in Halle 3, Stand ... beinhaltet die Sicherheitsplattform Qualcomm Haven™ – eine ...
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
Breaking Biology News(10 mins):